The R&D budget for health and medical sciences in the US is projected to rise steadily from $39.74 billion in 2024 to $41.36 billion in 2028, marking consistent year-on-year increases of approximately 1% to 1.2%. From 2023, the R&D funding shows a continued focus on growth. Over a five-year span, the compounded annual growth rate (CAGR) is expected to maintain a subtle yet positive uptrend.

Future trends to watch for include:

Increased investment in personalized medicine and biotechnology.
Emerging technologies such as AI and machine learning integration in healthcare.
Focus on pandemic preparedness and infectious disease research.
Shifts due to regulatory policies under changing administrations.